Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Refractory relapsing polychondritis: rapid and sustained response in the treatment with an IL-1 receptor antagonist (anakinra).

Literature DB >> 16510529

Refractory relapsing polychondritis: rapid and sustained response in the treatment with an IL-1 receptor antagonist (anakinra).

P Vounotrypidis, G T Sakellariou, D Zisopoulos, C Berberidis.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2006 PMID： 16510529 DOI： 10.1093/rheumatology/kel041

Source DB: PubMed Journal: Rheumatology (Oxford) ISSN： 1462-0324 Impact factor: 7.580

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Tailoring biological treatment: anakinra treatment of posterior uveitis associated with the CINCA syndrome.

Authors: S C B Teoh; S Sharma; A Hogan; R Lee; A V Ramanan; A D Dick
Journal: Br J Ophthalmol Date: 2007-02 Impact factor: 4.638

Review 2. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors: D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal: Ann Rheum Dis Date: 2007-11 Impact factor: 19.103

Review 3. Relapsing polychondritis: a review.

Authors: Aman Sharma; Karthik Gnanapandithan; Kusum Sharma; Susmita Sharma
Journal: Clin Rheumatol Date: 2013-07-26 Impact factor: 2.980

4. Relapsing polychondritis: new therapeutic strategies with biological agents.

Authors: Paola Sabrina Buonuomo; Claudia Bracaglia; Andrea Campana; Maya El Hachem; Andrea Diociaiuti; Antonella Insalaco; Fabrizio De Benedetti; Beatrice Chiarini Testa; Elisabetta Cortis; Giovanni Carlo De Vincentiis; Alberto G Ugazio
Journal: Rheumatol Int Date: 2009-08-15 Impact factor: 2.631

Refractory relapsing polychondritis: rapid and sustained response in the treatment with an IL-1 receptor antagonist (anakinra).

1. Tailoring biological treatment: anakinra treatment of posterior uveitis associated with the CINCA syndrome.

Review 2. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Review 3. Relapsing polychondritis: a review.

4. Relapsing polychondritis: new therapeutic strategies with biological agents.

5. [Recommendations on therapy using interleukin-1beta-blocking agents].

Review 6. The NLRP3 inflammasome in health and disease: the good, the bad and the ugly.

Review 7. Relapsing polychondritis: a chameleon among orphan diseases.

8. [IL-1 antagonists].

Review 9. An expanding role for interleukin-1 blockade from gout to cancer.

10. Functional relevance of NLRP3 inflammasome-mediated interleukin (IL)-1β during acute allergic airway inflammation.